Form 8-K - Current report:
SEC Accession No. 0001099800-23-000003
Filing Date
2023-01-31
Accepted
2023-01-31 16:31:12
Documents
14
Period of Report
2023-01-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ew-20230131.htm   iXBRL 8-K 42504
2 EX-99.1 ex-991q42022.htm EX-99.1 460264
6 LOGO ew45percentblacklrga21.jpg GRAPHIC 640161
  Complete submission text file 0001099800-23-000003.txt   1543832

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ew-20230131.xsd EX-101.SCH 1906
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ew-20230131_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ew-20230131_pre.xml EX-101.PRE 12516
8 EXTRACTED XBRL INSTANCE DOCUMENT ew-20230131_htm.xml XML 11373
Mailing Address ONE EDWARDS WAY IRVINE CA 92614
Business Address ONE EDWARDS WAY IRVINE CA 92614 9492502500
Edwards Lifesciences Corp (Filer) CIK: 0001099800 (see all company filings)

EIN.: 364316614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15525 | Film No.: 23572978
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies